These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

466 related items for PubMed ID: 29522534

  • 1. Niemann-Pick type C2 protein supplementation in experimental non-alcoholic fatty liver disease.
    Christensen CU, Glavind E, Thomsen KL, Kim YO, Heebøll S, Schuppan D, Hamilton-Dutoit S, Würtz Heegaard C, Grønbæk H.
    PLoS One; 2018; 13(3):e0192728. PubMed ID: 29522534
    [Abstract] [Full Text] [Related]

  • 2. Preventive effect of trans-chalcone on non-alcoholic steatohepatitis: Improvement of hepatic lipid metabolism.
    Karimi-Sales E, Ebrahimi-Kalan A, Alipour MR.
    Biomed Pharmacother; 2019 Jan; 109():1306-1312. PubMed ID: 30551380
    [Abstract] [Full Text] [Related]

  • 3. Biochemical and histological characterisation of an experimental rodent model of non-alcoholic steatohepatitis - Effects of a peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist and a glucagon-like peptide-1 analogue.
    Daniels SJ, Leeming DJ, Detlefsen S, Bruun MF, Hjuler ST, Henriksen K, Hein P, Karsdal MA, Brockbank S, Cruwys S.
    Biomed Pharmacother; 2019 Mar; 111():926-933. PubMed ID: 30841472
    [Abstract] [Full Text] [Related]

  • 4. Involvement of hepatic peroxisome proliferator-activated receptor α/γ in the therapeutic effect of osthole on high-fat and high-sucrose-induced steatohepatitis in rats.
    Zhao X, Xue J, Wang XL, Zhang Y, Deng M, Xie ML.
    Int Immunopharmacol; 2014 Sep; 22(1):176-81. PubMed ID: 24993341
    [Abstract] [Full Text] [Related]

  • 5. Overactivation of intestinal sterol response element-binding protein 2 promotes diet-induced nonalcoholic steatohepatitis.
    Malhotra P, Aloman C, Ankireddy A, Khadra H, Ooka K, Gill RK, Saksena S, Dudeja PK, Alrefai WA.
    Am J Physiol Gastrointest Liver Physiol; 2017 Nov 01; 313(5):G376-G385. PubMed ID: 28774869
    [Abstract] [Full Text] [Related]

  • 6. Elevated free cholesterol in a p62 overexpression model of non-alcoholic steatohepatitis.
    Simon Y, Kessler SM, Gemperlein K, Bohle RM, Müller R, Haybaeck J, Kiemer AK.
    World J Gastroenterol; 2014 Dec 21; 20(47):17839-50. PubMed ID: 25548482
    [Abstract] [Full Text] [Related]

  • 7. Aerobic exercise training in the treatment of non-alcoholic fatty liver disease related fibrosis.
    Linden MA, Sheldon RD, Meers GM, Ortinau LC, Morris EM, Booth FW, Kanaley JA, Vieira-Potter VJ, Sowers JR, Ibdah JA, Thyfault JP, Laughlin MH, Rector RS.
    J Physiol; 2016 Sep 15; 594(18):5271-84. PubMed ID: 27104887
    [Abstract] [Full Text] [Related]

  • 8. Niemann-Pick Type C2 Protein Mediates Hepatic Stellate Cells Activation by Regulating Free Cholesterol Accumulation.
    Twu YC, Lee TS, Lin YL, Hsu SM, Wang YH, Liao CY, Wang CK, Liang YC, Liao YJ.
    Int J Mol Sci; 2016 Jul 13; 17(7):. PubMed ID: 27420058
    [Abstract] [Full Text] [Related]

  • 9. Effects of combined PPAR-γ and PPAR-α agonist therapy on fructose induced NASH in rats: Modulation of gene expression.
    Abd El-Haleim EA, Bahgat AK, Saleh S.
    Eur J Pharmacol; 2016 Feb 15; 773():59-70. PubMed ID: 26825546
    [Abstract] [Full Text] [Related]

  • 10. ABCA1-dependent mobilization of lysosomal cholesterol requires functional Niemann-Pick C2 but not Niemann-Pick C1 protein.
    Boadu E, Nelson RC, Francis GA.
    Biochim Biophys Acta; 2012 Mar 15; 1821(3):396-404. PubMed ID: 22179027
    [Abstract] [Full Text] [Related]

  • 11. The Combination of Blueberry Juice and Probiotics Ameliorate Non-Alcoholic Steatohepatitis (NASH) by Affecting SREBP-1c/PNPLA-3 Pathway via PPAR-α.
    Ren T, Zhu J, Zhu L, Cheng M.
    Nutrients; 2017 Feb 27; 9(3):. PubMed ID: 28264426
    [Abstract] [Full Text] [Related]

  • 12. PPARα/γ agonists and antagonists differently affect hepatic lipid metabolism, oxidative stress and inflammatory cytokine production in steatohepatitic rats.
    Zhang Y, Cui Y, Wang XL, Shang X, Qi ZG, Xue J, Zhao X, Deng M, Xie ML.
    Cytokine; 2015 Sep 27; 75(1):127-35. PubMed ID: 26194065
    [Abstract] [Full Text] [Related]

  • 13. Obeticholic acid raises LDL-cholesterol and reduces HDL-cholesterol in the Diet-Induced NASH (DIN) hamster model.
    Briand F, Brousseau E, Quinsat M, Burcelin R, Sulpice T.
    Eur J Pharmacol; 2018 Jan 05; 818():449-456. PubMed ID: 29155143
    [Abstract] [Full Text] [Related]

  • 14. Molecular drivers of non-alcoholic steatohepatitis are sustained in mild-to-late fibrosis progression in a guinea pig model.
    Ipsen DH, Skat-Rørdam J, Tsamouri MM, Latta M, Lykkesfeldt J, Tveden-Nyborg P.
    Mol Genet Genomics; 2019 Jun 05; 294(3):649-661. PubMed ID: 30759275
    [Abstract] [Full Text] [Related]

  • 15. Co-Administration of Cholesterol-Lowering Probiotics and Anthraquinone from Cassia obtusifolia L. Ameliorate Non-Alcoholic Fatty Liver.
    Mei L, Tang Y, Li M, Yang P, Liu Z, Yuan J, Zheng P.
    PLoS One; 2015 Jun 05; 10(9):e0138078. PubMed ID: 26375281
    [Abstract] [Full Text] [Related]

  • 16. Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.
    Ganz M, Bukong TN, Csak T, Saha B, Park JK, Ambade A, Kodys K, Szabo G.
    J Transl Med; 2015 Jun 16; 13():193. PubMed ID: 26077675
    [Abstract] [Full Text] [Related]

  • 17. Elafibranor, an Agonist of the Peroxisome Proliferator-Activated Receptor-α and -δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening.
    Ratziu V, Harrison SA, Francque S, Bedossa P, Lehert P, Serfaty L, Romero-Gomez M, Boursier J, Abdelmalek M, Caldwell S, Drenth J, Anstee QM, Hum D, Hanf R, Roudot A, Megnien S, Staels B, Sanyal A, GOLDEN-505 Investigator Study Group.
    Gastroenterology; 2016 May 16; 150(5):1147-1159.e5. PubMed ID: 26874076
    [Abstract] [Full Text] [Related]

  • 18. Effect of resveratrol on experimental non-alcoholic steatohepatitis.
    Heebøll S, Thomsen KL, Clouston A, Sundelin EI, Radko Y, Christensen LP, Ramezani-Moghadam M, Kreutzfeldt M, Pedersen SB, Jessen N, Hebbard L, George J, Grønbæk H.
    Pharmacol Res; 2015 May 16; 95-96():34-41. PubMed ID: 25814186
    [Abstract] [Full Text] [Related]

  • 19. Pathological characterization and morphometric analysis of hepatic lesions in SHRSP5/Dmcr, an experimental non-alcoholic steatohepatitis model, induced by high-fat and high-cholesterol diet.
    Horai Y, Utsumi H, Ono Y, Kishimoto T, Ono Y, Fukunari A.
    Int J Exp Pathol; 2016 Feb 16; 97(1):75-85. PubMed ID: 27037502
    [Abstract] [Full Text] [Related]

  • 20. Osthol ameliorates fat milk-induced fatty liver in mice by regulation of hepatic sterol regulatory element-binding protein-1c/2-mediated target gene expression.
    Du R, Xue J, Wang HB, Zhang Y, Xie ML.
    Eur J Pharmacol; 2011 Sep 16; 666(1-3):183-8. PubMed ID: 21620823
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.